Radiofrequency Ablation of Malignant Liver Tumors
New Approaches to the Treatment of Hepatic Malignancies
Received: 18 July 2002 Accepted: 15 August 2002 DOI:
Cite this article as: Curley, S.A. Ann Surg Oncol (2003) 10: 338. doi:10.1245/ASO.2003.07.017 Abstract Background: Radiofrequency ablation (RFA) is being used to treat primary and metastatic liver tumors. The indications, treatment planning, and limitations of hepatic RFA must be defined and refined by surgeons treating hepatic malignancies. Methods: A review of the experience using RFA to treat unresectable primary and secondary hepatic malignancies at the University of Texas M. D. Anderson Cancer Center in Houston, Texas, and the G. Pascale National Cancer Institute in Naples, Italy, is provided. Patient selection, treatment approach, local recurrence rates, and overall cancer recurrence rates following RFA are described. The current literature on RFA of hepatic malignancies is reviewed. Results: RFA of hepatic tumors can be performed percutaneously, laparoscopically, or during an open surgical procedure. Incomplete treatment manifest as local recurrence is more common with a percutaneous approach. The morbidity and mortality rates associated with hepatic RFA are low. Local recurrence rates are low if meticulous treatment planning is performed. RFA can be combined safely with partial hepatic resection of large lesions. The long-term survival rates following RFA of primary and metastatic liver tumors have not yet been established. Conclusions: RFA of hepatic malignancies is a safe and promising technique to produce coagulative necrosis of unresectable hepatic malignancies. Experience with this treatment modality is not yet mature enough to establish long-term outcomes. Key Words: Radiofrequency ablation Liver cancer Coagulation necrosis Thermal ablation REFERENCES
LeVeen RF. Laser hyperthermia and radiofrequency ablation of hepatic lesions.
Semin Interven Radiol 1997;14:313–24.
Dickson JA, Calderwood SK. Temperature range and selective sensitivity of tumors to hyperthermia: a critical review.
Ann N Y Acad Sci
Hill RP, Hunt JW. Hyperthermia Tannock IF, Hill RP Eds.
The Basic Science of Oncology. New York: Pergamon Press, 1987: 337–57.
Haines DE, Watson DD, Halperin C. Characteristics of heat transfer and determination of temperature gradient and viability threshold during radiofrequency fulguration of isolated perfused canine right ventricle.
Grundfest WS, Litvack FI, Doyle DL. Laser-tissue interactions: considerations for cardiovascular applications White RA, Grundfest WS Eds.
Lasers in Cardiovascular Disease. Chicago: Yearbook Medical Publishers, 1987: 32–43.
Bischof J, Christov K, Rubinsky B. A morphological study of cooling rate response in normal and neoplastic human liver tissue: cryosurgical implications.
Steeves RA. Hyperthermia in cancer therapy: where are we today and where are we going?
Bull N Y Acad Med
Siperstein AE, Rogers SJ, Hansen PD, Gitomirsky A. Laparoscopic thermal ablation of hepatic neuroendocrine tumor metastases.
Goldburg SN, Gazelle GS, Solbiati L. Ablation of liver tumors using percutaneous RF therapy.
Am J Res 1998;170:1023–8.
Lencioni R, Goletti O, Armillotta N, et al. Radio-frequency thermal ablation of liver metastases with a cooled-tip electrode needle: results of a pilot clinical trial.
Nagata Y, Hiraoka M, Nishimura Y, et al. Clinical results of radiofrequency hyperthermia for malignant liver tumors.
Int J Radiat Oncol Biol Phys
McGahan JP, Brock JM, Tesluk H, Gu WZ, Schneider P, Browning PD. Hepatic ablation with use of radio-frequency electrocautery in the animal model.
J Vasc Interv Radiol
Curley SA, Izzo F, Delrio P, et al. Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients.
Curley S, Izzo F, Ellis LM, Woodall M, Wolff R, Vauthey JN. Radiofrequency ablation of malignant liver tumors in 304 patients. Paper presented at: Proceedings ASCO; May 2000; New Orleans, LA.
Tuttle T. Hepatectomy for noncolorectal liver metastases Curley SA Eds.
Liver Cancer. New York: Springer-Verlag Publishers, 1998: 201–11.
Curley SA, Davidson BS, Fleming RY, et al. Laparoscopically guided bipolar radiofrequency ablation of areas of porcine liver.
Curley SA, Izzo F, Ellis LM, Nicolas Vauthey J, Vallone P. Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis.
Patterson J, Strang R. The role of blood flow in hyperthermia.
Int J Radiat Oncol Biol Phys
Kolios MC, Sherar MD, Hunt JW. Large blood vessel cooling in heated tissues: a numerical study.
Phys Med Biol
Sturesson C, Liu DL, Stenram U, Andersson-Engels S. Hepatic inflow occlusion increases the efficacy of interstitial laser-induced thermotherapy in rat.
J Surg Res
Curley SA. Radiofrequency ablation of malignant liver tumors.
Solbiati L, Ierace T, Tonolini M, Osti V, Cova L. Radiofrequency thermal ablation of hepatic metastases.
Eur J Ultrasound
Siperstein A, Garland A, Engle K, et al. Local recurrence after laparoscopic radiofrequency thermal ablation of hepatic tumors.
Ann Surg Oncol
Wood TF, Rose DM, Chung M, Allegra DP, Foshag LJ, Bilchik AJ. Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications.
Ann Surg Oncol
Bowles BJ, Machi J, Limm WM, et al. Safety and efficacy of radiofrequency thermal ablation in advanced liver tumors.
de Baere T, Elias D, Dromain C, et al. Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year.
AJR Am J Roentgenol
Siperstein AE, Berber E. Cryoablation, percutaneous alcohol injection, and radiofrequency ablation for treatment of neuroendocrine liver metastases.
World J Surg
Wessels FJ, Schell SR. Radiofrequency ablation treatment of refractory carcinoid hepatic metastases.
J Surg Res
Choi H, Loyer EM, Dubrow RA, et al. Radiofrequency ablation (RFA) of liver tumors: assessment of therapeutic response and complications.
Catalano O, Lobianco R, Esposito M, Siani A. Hepatocellular carcinoma recurrence after percutaneous ablation therapy: helical CT patterns.
Cioni D, Lencioni R, Bartolozzi C. Percutaneous ablation of liver malignancies: imaging evaluation of treatment response.
Eur J Ultrasound
Cedrone A, Pompili M, Sallustio G, Lorenzelli GP, Gasbarrini G, Rapaccini GL. Comparison between color power Doppler ultrasound with echo-enhancer and spiral computed tomography in the evaluation of hepatocellular carcinoma vascularization before and after ablation procedures.
Am J Gastroenterol
Ravikumar TS, Jones M, Serrano M, Kaleya R, Valdivia A, Mil-stein DM. The role of PET scanning in radiofrequency ablation of liver metastasis from colorectal cancer.
Cancer Journal 2000; 6(Suppl 4):S330–S43.
Donckier V, Luc Van Laethem J, Feron P, et all., Contribution of FDG positron emission tomography in the evaluation of the treatment of liver metastasis using radiofrequency ablation. (in press).
© The Society of Surgical Oncology, Inc. 2003